{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:53:05Z","timestamp":1786114385802,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["P01 HL158506"],"award-info":[{"award-number":["P01 HL158506"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.04.056","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:25:10Z","timestamp":1777674310000},"page":"4531-4545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["AAVrh32.33 capsid demonstrates unexpected dermal tropism regardless of immunodominant epitope"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6900-5668","authenticated-orcid":false,"given":"Motahareh","family":"Arjomandnejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsley","family":"Essien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Sylvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Blackwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Tutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5202-4616","authenticated-orcid":false,"given":"Allison M.","family":"Keeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.04.056_bib1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/jdv.18050","article-title":"Prevalence of most common skin diseases in Europe: a population-based study","volume":"36","author":"Richard","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib2","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v103.12404","article-title":"Incidence and Prevalence of 73 Different Genodermatoses: A Nationwide Study in Sweden","volume":"103","author":"Zagoras","year":"2023","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrm2636","article-title":"Epidermal homeostasis: a balancing act of stem cells in the skin","volume":"10","author":"Blanpain","year":"2009","journal-title":"Nat. Rev. Mol. Cel Biol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1096323","article-title":"Virus induced dysbiosis promotes type 1 diabetes onset","volume":"14","author":"Morse","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1172\/JCI10575","article-title":"Gene therapy in the treatment of autoimmune diseases","volume":"106","author":"Tsokos","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.04.056_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tibtech.2020.07.012","article-title":"Gene Delivery to the Skin - How Far Have We Come?","volume":"39","author":"Ain","year":"2021","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.04.056_bib9","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.ymthe.2025.04.045","article-title":"Current clinical applications of AAV-mediated gene therapy","volume":"33","author":"Byrne","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.04.056_bib10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.celrep.2019.03.105","article-title":"In Situ Modification of Tissue Stem and Progenitor Cell Genomes","volume":"27","author":"Goldstein","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.04.056_bib11","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1089\/ten.2004.10.1707","article-title":"Generation of recombinant skin in vitro by adeno-associated virus type 2 vector transduction","volume":"10","author":"Agrawal","year":"2004","journal-title":"Tissue Eng."},{"key":"10.1016\/j.ymthe.2026.04.056_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jss.2013.03.051","article-title":"Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications","volume":"184","author":"Balaji","year":"2013","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ymthe.2026.04.056_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40259-023-00585-7","article-title":"Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer","volume":"37","author":"Arjomandnejad","year":"2023","journal-title":"BioDrugs."},{"key":"10.1016\/j.ymthe.2026.04.056_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jdermsci.2024.07.006","article-title":"Optimization of an adeno-associated viral vector for epidermal keratinocytes in vitro and in vivo","volume":"115","author":"Shen","year":"2024","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ymthe.2026.04.056_bib15","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.4049\/jimmunol.0803965","article-title":"Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins","volume":"182","author":"Mays","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/jgm.1402","article-title":"Identification of the murine AAVrh32.33 capsid-specific CD8+ T cell epitopes","volume":"11","author":"Mays","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2026.04.056_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.101052","article-title":"Flow cytometry analysis of the subpopulations of mouse keratinocytes and skin immune cells","volume":"3","author":"Sakamoto","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.ymthe.2026.04.056_bib18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.omtm.2021.10.010","article-title":"Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells. Molecular therapy","volume":"23","author":"Arjomandnejad","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.04.056_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jsb.2014.03.020","article-title":"The structure of AAVrh32.33, a novel gene delivery vector","volume":"186","author":"Mikals","year":"2014","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib20","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/jid.2015.26","article-title":"CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo","volume":"135","author":"Eby","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib21","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jid.2022.05.1090","article-title":"Regulatory T Cells Require CCR6 for Skin Migration and Local Suppression of Vitiligo","volume":"142","author":"Essien","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112306","article-title":"The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity","volume":"18","author":"Scheu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.04.056_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00262-015-1675-7","article-title":"CCL17 and CCL22\/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer\/T-cell lymphoma","volume":"64","author":"Kumai","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2026.04.056_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115294","article-title":"Challenges and progress related to gene editing in rare skin diseases","volume":"208","author":"Pi\u00f1\u00f3n Hofbauer","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2026.04.056_bib25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/mt.2014.14","article-title":"Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy","volume":"22","author":"Sallach","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.04.056_bib26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cell.2020.06.031","article-title":"Cell Types Promoting Goosebumps Form a Niche to Regulate Hair Follicle Stem Cells","volume":"182","author":"Shwartz","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.04.056_bib27","article-title":"Identification of CD164 as an essential entry receptor for divergent adeno-associated viruses","volume":"123","author":"Zhang","year":"2026","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.04.056_bib28","first-page":"3113","article-title":"Functionally defined CD164 epitopes are expressed on CD34+ cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues","volume":"95","author":"Watt","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.04.056_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41536-021-00143-1","article-title":"The stem cell revolution: on the role of CD164 as a human stem cell marker","volume":"6","author":"Watt","year":"2021","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.ymthe.2026.04.056_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.04.056_bib31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI57414","article-title":"Dissecting the bulge in hair regeneration","volume":"122","author":"Myung","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.04.056_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF00216434","article-title":"Regional differences in renewal rates of fibroblasts in young adult female mice","volume":"232","author":"Ruchti","year":"1983","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ymthe.2026.04.056_bib33","doi-asserted-by":"crossref","first-page":"9286","DOI":"10.1038\/s41467-024-53295-1","article-title":"Epigenetic memory of radiotherapy in dermal fibroblasts impairs wound repair capacity in cancer survivors","volume":"15","author":"Bian","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.056_bib34","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1016\/j.cell.2023.07.031","article-title":"Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB)","volume":"186","author":"Epstein","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.04.056_bib35","first-page":"407","article-title":"FDA approves cell-sheet-based gene therapy for severe skin disease","volume":"24","author":"Mullard","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.04.056_bib36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/bjd\/ljad528","article-title":"Topical gene editing therapeutics using lipid nanoparticles: \u2018gene creams\u2019 for genetic skin diseases?","volume":"190","author":"Guri-Lamce","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2024.01.036","article-title":"Skin electroporation for transdermal drug delivery: Electrical measurements, numerical model and molecule delivery","volume":"367","author":"Kougkolos","year":"2024","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2026.04.056_bib38","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial","volume":"77","author":"Mendell","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib39","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.04.056_bib40","article-title":"Purification of Recombinant Adeno-Associated Viruses (rAAVs) by Cesium Chloride Gradient Sedimentation","volume":"2020","author":"Su","year":"2020","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.ymthe.2026.04.056_bib41","first-page":"11","article-title":"Production and discovery of novel recombinant adeno-associated viral vectors","volume":"14","author":"Mueller","year":"2012","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.ymthe.2026.04.056_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.04.056_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.695","article-title":"A Mouse Model of MC903-Induced Atopic Dermatitis","volume":"3","author":"Alam","year":"2023","journal-title":"Curr. Protoc."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626003771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626003771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T20:45:33Z","timestamp":1785962733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626003771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1525001626003771"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.056","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAVrh32.33 capsid demonstrates unexpected dermal tropism regardless of immunodominant epitope","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}